Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000930413-22-000319
Filing Date
2022-02-23
Accepted
2022-02-23 16:36:39
Documents
1
Group Members
KIMBERLY PAGERICHARD ABBE

Document Format Files

Seq Description Document Type Size
1 c103099_sc13ga.htm SC 13G/A 52496
  Complete submission text file 0000930413-22-000319.txt   54249
Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

EIN.: 010786483 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Subject) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 0831
Type: SC 13G/A | Act: 34 | File No.: 005-90653 | Film No.: 22664409
SIC: 2834 Pharmaceutical Preparations